CLAIMS
CLAIMS
CLAIMS - Clinical impact through AI-assisted MS care
The CLAIMS project aims to address the urgent need for a more data-driven and personalized clinical decision-support tool for patients with Multiple Sclerosis, one that addresses the new insights in disease worsening due to both relapses and disease progression independent of relapses, and as such supports optimal treatment decisions and improved long-term patient outcomes. As such, our mission is to develop, validate, and seek regulatory approval for a companion diagnostic platform that provides a holistic view of each patient. This platform will visualize existing and new biomarker data, as well as predict disease trajectories under different treatment scenarios while accounting for comorbidities. Powered by deep-learning-based disease subtyping and progression models, this platform aims to enhance the precision of MS care, extending the patients’ quality-adjusted life years, and reducing the economic burden on both individuals and society.
CLAIMS is supported by the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101112153. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, EuropaBio, MedTech Europe, Vaccines Europe, AB Science SA and icometrix NV.